Google-backed, AI-developed drugs are headed to trial by 2026, DeepMind CEO says

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Read more…

​Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.Read more… 

Leave a Reply

Your email address will not be published. Required fields are marked *